ARTICLE | Company News
NeXstar Pharmaceuticals Inc. (NXTR), Supragen Inc. deal
September 18, 1995 7:00 AM UTC
NXTR (Boulder, Colo.) completed its previously announced acquisition of Supragen, a privately held developer of therapeutics and vaccines for T cell-mediated diseases, by issuing 751,597 shares of NXT...